CI stock · GKOS stock

CI vs GKOS · P/E 2.4, rev $274.90B vs rev $383.5M

Cigna Corp (CI) versus Glaukos Corp (GKOS) — a side-by-side from cached financials, not a winner call.

Cigna Corp (CI) is a healthcare plans company listed on US.

Glaukos Corp (GKOS) is a medical devices company listed on NYSE.

Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.

Latest reported GKOS revenue for 2024-12-31 was $383.5M. Net income was -$146.4M. Revenue was up 21.9% from 2023-12-31 to 2024-12-31. GKOS currently screens at market cap $7.63B.

CI currently screens at market cap $71.62B and trailing P/E 2.4. GKOS currently screens at market cap $7.63B.

Not investment advice. Open the CI and GKOS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons